N. ANTHONY COLES - 13 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
By: Beverly Dubs as attorney-in-fact For: N. Anthony Coles
Issuer symbol
REGN
Transactions as of
13 Aug 2021
Net transactions value
-$559,060
Form type
4
Filing time
16 Aug 2021, 16:04:52 UTC
Next filing
19 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $690,940 +2,000 +222% $345.47 2,902 13 Aug 2021 Direct F1
transaction REGN Common Stock Sale $1,250,000 -2,000 -69% $625.00 902 13 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,000 -15% $0.000000 11,039 13 Aug 2021 Common Stock 2,000 $345.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.